HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael W Sill Selected Research

Wounds and Injuries (Trauma)

10/2017Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael W Sill Research Topics

Disease

34Neoplasms (Cancer)
11/2020 - 08/2005
22Disease Progression
01/2020 - 09/2007
20Carcinoma (Carcinomatosis)
10/2020 - 08/2005
14Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 09/2008
14Endometrial Neoplasms (Endometrial Cancer)
12/2019 - 05/2007
8Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2020 - 03/2009
5Hypertension (High Blood Pressure)
02/2018 - 11/2007
5Pain (Aches)
07/2015 - 11/2007
5Ovarian Epithelial Carcinoma
03/2012 - 11/2007
4Neutropenia
01/2017 - 07/2008
4Carcinosarcoma
11/2012 - 05/2010
3Fistula
10/2017 - 03/2009
3Leiomyosarcoma
01/2017 - 09/2007
3Anemia
07/2015 - 03/2009
3Fatigue
07/2015 - 07/2009
3Vomiting
08/2012 - 09/2011
3Thrombocytopenia (Thrombopenia)
04/2012 - 02/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 03/2009
2Body Weight (Weight, Body)
10/2020 - 02/2014
2Diarrhea
01/2019 - 02/2011
2Abdominal Pain (Pain, Abdominal)
01/2019 - 04/2012
2Nausea
01/2019 - 04/2012
2Thromboembolism
10/2017 - 11/2007
2Dyspnea (Shortness of Breath)
07/2015 - 11/2007
2Febrile Neutropenia
04/2012 - 02/2011
1Hypoxia (Hypoxemia)
02/2018
1Wounds and Injuries (Trauma)
10/2017
1Hemorrhage
10/2017
1Uterine Cervical Dysplasia
01/2017
1Intestinal Fistula
01/2016
1Necrosis
01/2016
1Vascular Remodeling
09/2015
1Edema (Dropsy)
07/2015
1Neoplasm Metastasis (Metastasis)
12/2012
1Migraine Disorders (Migraine)
08/2012

Drug/Important Bio-Agent (IBA)

16Bevacizumab (Avastin)FDA Link
11/2020 - 11/2007
15Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 09/2008
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 11/2007
8Cisplatin (Platino)FDA LinkGeneric
10/2017 - 10/2009
7Carboplatin (JM8)FDA LinkGeneric
12/2012 - 09/2008
5Pharmaceutical PreparationsIBA
11/2020 - 07/2009
5Biomarkers (Surrogate Marker)IBA
02/2018 - 05/2007
5PlatinumIBA
06/2014 - 03/2011
4Topotecan (Hycamtin)FDA LinkGeneric
10/2017 - 03/2011
4ErbB Receptors (EGF Receptor)IBA
06/2013 - 08/2005
4Docetaxel (Taxotere)FDA Link
12/2012 - 12/2009
3Cetuximab (Erbitux)FDA Link
12/2012 - 05/2011
3Thalidomide (Thalomid)FDA Link
11/2012 - 05/2007
2fosbretabulin (combretastatin A4)IBA
10/2020 - 01/2016
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2019 - 07/2015
2Phosphotransferases (Kinase)IBA
01/2019 - 11/2018
2pazopanibFDA Link
02/2018 - 01/2018
2Proteins (Proteins, Gene)FDA Link
10/2017 - 05/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2015 - 12/2009
2Tyrosine Kinase InhibitorsIBA
10/2014 - 11/2012
2Gefitinib (Iressa)FDA Link
06/2013 - 08/2005
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2013 - 11/2012
2Lapatinib (GW572016)FDA Link
11/2012 - 03/2012
2Imatinib Mesylate (Gleevec)FDA Link
05/2010 - 07/2008
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
05/2010 - 07/2008
2paclitaxel poliglumex (XYOTAX)IBA
12/2008 - 09/2008
1TubulinIBA
10/2020
1Angiogenesis InhibitorsIBA
10/2020
1IpilimumabIBA
01/2020
1NivolumabIBA
01/2020
1GSK2141795IBA
12/2019
1trametinibIBA
12/2019
1tyrosine receptor (receptor, tyrosine)IBA
01/2019
1cabozantinibIBA
01/2019
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2019
1EverolimusFDA Link
11/2018
1Interleukin-8 (Interleukin 8)IBA
02/2018
1CreatinineIBA
10/2017
1MLN 8237IBA
01/2017
1Celecoxib (Celebrex)FDA Link
01/2017
1Tromethamine (Trometamol)FDA Link
01/2016
1cediranib (AZD2171)IBA
09/2015
1trebananibIBA
09/2015
1Angiopoietin-1IBA
09/2015
1AZD 6244IBA
07/2015
1Mitogen-Activated Protein KinasesIBA
07/2015
1Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2015
1veliparibIBA
06/2015
1nintedanibIBA
12/2014
1brivanibIBA
10/2014
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2014
1CholesterolIBA
06/2014
1poly(ethylene glycol)-co-poly(ethyleneimine)IBA
06/2014
1Interleukin-12 (IL 12)IBA
06/2014
1Estrogen ReceptorsIBA
06/2013
1progesterone receptor AIBA
06/2013
1afliberceptIBA
12/2012
1Growth Factor ReceptorsIBA
12/2012
1iniparibIBA
09/2012

Therapy/Procedure

13Drug Therapy (Chemotherapy)
01/2020 - 05/2007
12Therapeutics
10/2020 - 09/2008
3Radiotherapy
02/2014 - 04/2012
1Hysterectomy
09/2015
1TP protocol
07/2015
1Combination Drug Therapy (Combination Chemotherapy)
02/2014